article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Billion by 2026. Reasons for Low Investment: High regulatory hurdles: Drug development for pain is historically challenging with a high failure rate due to complex pain mechanisms and stringent regulatory requirements. Remote patient monitoring: Continuous data collection for proactive intervention and improved outcomes.